TX SB1102

Authorizes licensed midwives to administer drugs commonly used in labor or postpartum care, including antihemorrhagic drugs, intravenous fluids, and local anesthetics, as well as prophylactic drugs meeting applicable standards of care for women or newborns

Requires midwives to demonstrate training in administering these specified drugs as a condition of practicing midwifery in Texas

Mandates licensed midwives complete a continuing education course in pharmacology covering administration of the authorized drugs, in addition to existing continuing education requirements for license renewal

Specifies that drug administration by midwives under these provisions does not constitute the practice of medicine

Texas Commission of Licensing and Regulation must adopt implementing rules by December 1, 2025, with the new continuing education requirements and drug administration authority taking effect February 1, 2026